Stonegate Updates Coverage on NCS Multistage Holdings, Inc. (NCSM) Q126
Rhea-AI Summary
NCS Multistage (NASDAQ: NCSM) reported 1Q26 results below expectations as Canada and select international projects weighed on performance, while U.S. revenue more than doubled. Management and Stonegate maintained FY26 Adjusted EBITDA guidance, but shifted cadence toward a back-half recovery driven by deferred Canadian work, Repeat Precision activity, and ResMetrics synergies. The company reported positive free cash flow and $53M liquidity. Management said 2026 guidance excludes potential sliding sleeve deliveries for a first deepwater Gulf of Mexico opportunity that could materialize in late 2026 or early 2027.
AI-generated analysis. Not financial advice.
Positive
- U.S. revenue more than doubled in 1Q26
- Maintained FY26 Adjusted EBITDA guidance
- Positive free cash flow and $53M liquidity supporting integration
Negative
- 1Q26 missed expectations due to Canada and select international timing
- Guidance shift implies back-half-weighted recovery tied to deferred work
News Market Reaction – NCSM
On the day this news was published, NCSM declined 9.35%, reflecting a notable negative market reaction. Argus tracked a trough of -7.3% from its starting point during tracking. Our momentum scanner triggered 20 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $14M from the company's valuation, bringing the market cap to $136.48M at that time. Trading volume was above average at 1.7x the daily average, suggesting increased trading activity.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
NCSM’s sharp move contrasts with mixed peers: some like DTI (+7.81%) and SND (+4.36%) were up, while LSE, RCON and GEOS were modestly down and FET appeared in momentum scanners at -8.34%. This points to company-specific pressure rather than a broad sector selloff.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Apr 29 | Q1 2026 earnings | Negative | -28.1% | Revenue decline, margin compression and small net loss versus prior-year profit. |
| Apr 23 | Earnings call setup | Neutral | +1.1% | Announcement of Q1 2026 release date and investor conference call details. |
| Mar 06 | Stonegate FY25 update | Positive | +8.8% | Coverage highlighting FY25 revenue and EBITDA growth plus stronger free cash flow. |
| Mar 04 | Q4/FY25 earnings | Positive | +12.1% | Strong FY25 growth, higher Adjusted EBITDA and notable net income increase. |
| Feb 25 | Earnings call setup | Neutral | +3.0% | Scheduling of Q4 2025 earnings release and call logistics for investors. |
Earnings-related releases with strong results have seen positive reactions, while weaker quarters, like Q1 2026, prompted a steep selloff. Neutral scheduling and coverage notices have tended to see modest positive moves.
Over the last six months, NCS Multistage has progressed from strong FY25 results to a softer Q1 2026. Earlier, FY25 revenue of $183.6M and Adjusted EBITDA of $26.7M drove double‑digit positive reactions around March earnings events. The more recent Q1 2026 report, with revenues of $45.6M and an Adjusted EBITDA margin of 12%, triggered a -28.07% drop. Stonegate’s current update builds on that weaker quarter, emphasizing timing issues and a back‑half‑weighted recovery.
Market Pulse Summary
The stock moved -9.3% in the session following this news. The decline reflects how the market previously reacted to softer Q1 2026 results, which led to a -28.07% move after earnings. Stonegate’s update reiterates that Canada and international timing weighed on the quarter, even as U.S. revenue more than doubled. While FY26 Adjusted EBITDA guidance was maintained, the emphasis on a back‑half‑weighted recovery and project timing risk can heighten concern about near‑term visibility.
Key Terms
adjusted ebitda financial
free cash flow financial
sliding sleeve technical
AI-generated analysis. Not financial advice.
Dallas, Texas--(Newsfile Corp. - May 1, 2026) - NCS Multistage Holdings, Inc. (NASDAQ: NCSM): Stonegate Capital Partners Updates Coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM). NCSM's 1Q26 came in below expectations as Canada and select international projects weighed on results, while continued U.S. momentum helped offset the shortfall. In our view, the quarter does not change the core thesis around U.S. product momentum, ResMetrics integration, and the Company's capital-light model, but it does highlight the timing risk embedded in Canada seasonality and project-based international work. The key change is cadence, with 2Q26 guidance implying a softer near-term trough and maintained FY26 Adjusted EBITDA guidance pointing to a more back-half-weighted recovery tied to deferred Canadian work, recurring Repeat Precision activity, and ResMetrics synergies. Separately, management noted that 2026 guidance excludes potential sliding sleeve deliveries for its first deepwater Gulf of Mexico opportunity, which could materialize in late 2026 or early 2027.
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
- 1Q26 missed on Canada/international timing, but U.S. revenue more than doubled, preserving the thesis.
- FY26 EBITDA guide was maintained, shifting focus to 2H recovery and Repeat Precision execution.
- Positive FCF and
$53M liquidity support ResMetrics integration, capacity expansion, and growth investment.
Click image above to view full announcement.
About StonegateStonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies.
Contacts:
Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com
Source: Stonegate, Inc.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/295431